LOGIN
AAOS 2025: Efficacy of Autologous Dermal Fibroblast Injection - Retear Rate Post Rotator Cuff Repair
April 2025
AAOS 2025: Efficacy of Autologous Dermal Fibroblast Injection - Retear Rate Post Rotator Cuff Repair
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Efficacy of autologous dermal fibroblast injection in reducing retear rate after arthroscopic rotator cuff repair: a prospective randomized controlled clinical trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Seventy-two patients with full-thickness rotator cuff tears were randomized to receive either arthroscopic rotator cuff repair (ARCR) with intraoperative injection of autologous dermal fibroblasts (ADFs) (n=35) or ARCR alone (n=37). The primary outcome of interest was the retear rate assessed by MRI at 6 months postoperatively. Secondary outcomes included range of motion, ASES score, Constant scor...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.